We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6862:HKEXHaidilao International Holding Ltd. Analysis

Data as of 2026-03-15 - not real-time

NT$194.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading above its short‑term and mid‑term moving averages, reinforcing a bullish price trend, while the relative strength index sits near the midpoint, suggesting neither extreme overbought nor oversold conditions. However, the MACD indicator has turned bearish, the histogram is negative and volatility is elevated, highlighting short‑term downside pressure. The beta sits just above the market average, indicating modest systematic risk, and the price is comfortably above the identified support level but still below a strong resistance ceiling.
Fundamentally, revenue has contracted year‑over‑year yet the company maintains healthy gross and operating margins, and it delivers an attractive dividend yield with a payout ratio that approaches the higher end of sustainability. The discounted cash flow model places the fair value well below the current market price, implying the equity is overvalued at present, while the forward price‑earnings multiple is lower than the trailing figure, hinting at expected earnings improvement. Growth prospects in AI‑driven, automotive and charging‑station applications provide a compelling long‑term narrative, but dividend sustainability is uncertain given negative free cash flow.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price remains above short‑term averages
  • bearish MACD histogram signals near‑term weakness
  • elevated volatility raises short‑term uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • steady dividend yield with moderate payout ratio
  • solid operating margins despite revenue decline
  • exposure to expanding AI and automotive markets

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • consistent operating cash flow generation
  • strategic positioning in high‑growth end‑markets
  • potential for valuation correction as fundamentals improve

Key Metrics & Analysis

Financial Health

Revenue Growth-9.80%
Profit Margin18.30%
P/E Ratio21.8
ROE14.12%
ROA8.28%
Debt/Equity22.96
P/B Ratio3.3
Op. Cash FlowNT$585.6M
Free Cash FlowNT$-419514112
Industry P/E33.7

Technical Analysis

TrendBullish
RSI51.9
SupportNT$169.00
ResistanceNT$238.00
MA 20NT$190.73
MA 50NT$182.43
MA 200NT$159.42
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$114.31
Target PriceNT$170.00
Upside/Downside-12.37%
GradeOvervalued
TypeBlend
Dividend Yield3.09%

Risk Assessment

Beta1.03
Volatility84.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.